Usamos cookies essenciais para autenticação e preferências. Cookies de analytics são carregados apenas com seu consentimento. Saiba mais
The OTC and Consumer Health Market in the Netherlands Market volume, key players, opportunities, access requirements and a directory of Dutch importers and distribution partners for foreign suppliers of branded and private-label products Scope: OTC medicines, food supplements, self-care medical devices, health-related cosmetics Access requirements for suppliers from the EU, from non-EU Europe and from outside Europe Edition October 2026
Table of Contents
1. Executive Summary..........................................................................................................................................................3
2. Scope, Definitions and Market Delimitation....................................................................................................................3
2.1 Dispensing categories for OTC medicines.................................................................................................................4
3. Market Volume and Market Structure.............................................................................................................................4
3.1 Total market size.......................................................................................................................................................4
3.2 Market by product group..........................................................................................................................................5
3.3 Market by sales channel...........................................................................................................................................5
3.4 Key market trends.....................................................................................................................................................5
4. Major Market Players.......................................................................................................................................................6
4.1 Brand owners and manufacturers............................................................................................................................6
4.2 Retail and buying organisations................................................................................................................................6
4.3 Wholesale and distribution.......................................................................................................................................7
5. Distribution Channels and Routes to Market...................................................................................................................7
5.1 Typical listing process with Dutch retailers..............................................................................................................8
6. Market Opportunities for New Foreign Suppliers............................................................................................................8
6.1 Opportunities for branded products........................................................................................................................8
6.2 Opportunities for private label and no-name products...........................................................................................8
6.3 Success factors..........................................................................................................................................................9
7. Products and Product Groups with Good Sales Prospects...............................................................................................9
8. Market Access Requirements.........................................................................................................................................10
8.1 Requirements by product category (all suppliers).................................................................................................10
8.2 Suppliers from the European Union.......................................................................................................................11
8.3 Suppliers from non-EU European countries...........................................................................................................11
8.4 Suppliers from outside Europe...............................................................................................................................11
8.5 Overview: access requirements by supplier origin.................................................................................................12
9. Practical Market Entry Roadmap....................................................................................................................................12
10. Directory of Importers and Distribution Partners........................................................................................................13
10.A Pharmaceutical full-line wholesalers (pharmacy channel)..................................................................................13
10.B Drugstore, health-store and parapharmacy wholesalers.....................................................................................14
10.C OTC brand houses, licensing and distribution partners (pharma & OTC importers)...........................................15
10.D Drugstore and pharmacy chains...........................................................................................................................16
10.E Supermarket buying organisations.......................................................................................................................17
10.F Organic and natural product importers................................................................................................................18
10.G FMCG importers and full-range non-food distributors........................................................................................19
10.H Large online shops and marketplaces..................................................................................................................19
11. Key Institutions and Associations.................................................................................................................................20
12. Sources and Methodology............................................................................................................................................20
12.1 Methodology.........................................................................................................................................................20
12.2 Sources..................................................................................................................................................................21
1. Executive Summary
The Netherlands is a compact, highly organised and very price-conscious self-care market. According to the Dutch self-care industry association Neprofarm (data: IQVIA), consumers spent EUR 1.079 billion (consumer prices) on OTC medicines, food supplements, health products and self-care medical devices in 2025, an increase of only about 0.5–0.6% after strong growth of 7% in 2024. Around 195.6 million packs were sold. Volume declined slightly, so growth is currently driven by price and mix rather than by additional consumption. The market is dominated by one channel: drugstores account for 77.4% of tracked self-care sales, supermarkets for 14.9% and pharmacies for only 7.6%. The drugstore channel itself is highly concentrated. Kruidvat (A.S. Watson) alone operates close to 1,000 stores, followed by Etos (Ahold Delhaize), DA (Mosadex Group) and Holland & Barrett. Whoever wants to reach Dutch consumers at scale must therefore win listings with a handful of central buyers – or work with a Dutch distributor that already has these listings. Opportunities for foreign suppliers exist in three directions: • Branded products with a clear consumer benefit and proven success abroad can be launched through Dutch brand houses and distributors (e.g. Remark/Vision Healthcare, Holland Pharma, UniPharma, Emonta, Will-Pharma) that build brands on behalf of foreign owners. Growth categories are pain relief, digestive health, skin and hair, women’s health, sleep and healthy ageing. • Private label / no-name products are an important lever: Kruidvat alone carries more than 2,500 private-label items, and Etos, DA, Albert Heijn and the Superunie members all run strong own brands. Suppliers with competitive cost structures, EU-compliant documentation and reliable quality systems can bid for private-label contracts. • Digital and specialist channels (bol.com, Kruidvat marketplace, Vitaminstore, organic and health-food wholesale via Udea and Holland Pharma) offer lower-risk entry points to test demand before a nationwide drugstore roll-out. Access requirements depend heavily on the regulatory status of the product (medicine, food supplement, medical device, cosmetic or biocide). Suppliers from the EU benefit from the single market and mutual recognition, while suppliers from outside the EU must additionally organise an EU legal presence (marketing authorisation holder, importer with QP release, EU authorised representative or responsible person), customs clearance and, for food supplements, NVWA-compliant import. Dutch-language labelling, pre-approval of consumer advertising by the Keuringsraad (KOAG/KAG) and GS1 product data are practical must-haves in all cases. Chapter 10 contains a structured directory of Dutch importers, wholesalers, brand houses, retail buying organisations and online platforms with publicly available contact data for a first approach.
Confira o mercado, os setores e a data de revisão antes de comprar.
English